Viridian Therapeutics, Inc.\DE — Director's Dealing 2018

Feb 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIRAGEN THERAPEUTICS, INC. (MGEN)
CIK: 0001590750
Period of Report: 2018-02-21

Reporting Person: Marshall William Stuart (Director, President & CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	266896	Direct

Footnotes

F1: This filing relates to 1,250 shares acquired by the Reporting Person under the Miragen Therapeutics, Inc. 2016 Employee Stock Purchase Plan on February 21, 2018. None of the shares of common stock acquired herein were sold by the Reporting Person and all such shares are subject to a lock-up agreement between the Reporting Person and certain underwriters.